{"id":"https://openalex.org/W2139052378","doi":"https://doi.org/10.1128/aac.00527-13","title":"Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein","display_name":"Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein","publication_year":2013,"publication_date":"2013-04-30","ids":{"openalex":"https://openalex.org/W2139052378","doi":"https://doi.org/10.1128/aac.00527-13","mag":"2139052378","pmid":"https://pubmed.ncbi.nlm.nih.gov/23629699","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3697315"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00527-13","doi":"https://doi.org/10.1128/aac.00527-13","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00527-13","pdf_url":"https://aac.asm.org/content/aac/57/7/3250.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139052378"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/57/7/3250.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047564425","display_name":"Zhengxian Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhengxian Gu","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032509378","display_name":"Jason D. Graci","orcid":"https://orcid.org/0000-0002-6329-9164","observed_orcids":["https://orcid.org/0000-0002-6329-9164"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason D. Graci","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021596541","display_name":"Frederick C. Lahser","orcid":"https://orcid.org/0000-0003-4902-0435","observed_orcids":["https://orcid.org/0000-0003-4902-0435"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frederick C. Lahser","raw_affiliation_strings":["Merck Research Laboratories, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Kenilworth, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038834655","display_name":"Jamie J. Breslin","orcid":"https://orcid.org/0000-0001-7868-5669","observed_orcids":["https://orcid.org/0000-0001-7868-5669"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie J. Breslin","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030642413","display_name":"Stephen P. Jung","orcid":"https://orcid.org/0000-0002-9276-175X","observed_orcids":["https://orcid.org/0000-0002-9276-175X"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen P. Jung","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018684053","display_name":"James H. Crona","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James H. Crona","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083652322","display_name":"Patricia McMonagle","orcid":"https://orcid.org/0009-0007-8369-021X","observed_orcids":["https://orcid.org/0009-0007-8369-021X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia McMonagle","raw_affiliation_strings":["Merck Research Laboratories, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Kenilworth, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032844627","display_name":"Ellen Xia","orcid":"https://orcid.org/0009-0009-2593-4794","observed_orcids":["https://orcid.org/0009-0009-2593-4794"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellen Xia","raw_affiliation_strings":["Merck Research Laboratories, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Kenilworth, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shaotang Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaotang Liu","raw_affiliation_strings":["Merck Research Laboratories, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Kenilworth, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054254364","display_name":"Gary M. Karp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Karp","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012915781","display_name":"Jin Zhu","orcid":"https://orcid.org/0000-0003-3934-0312","observed_orcids":["https://orcid.org/0000-0003-3934-0312"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin Zhu","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020775571","display_name":"Song Huang","orcid":"https://orcid.org/0000-0002-6673-8812","observed_orcids":["https://orcid.org/0000-0002-6673-8812"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Song Huang","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050737001","display_name":"Amin A. Nomeir","orcid":"https://orcid.org/0000-0002-8394-9056","observed_orcids":["https://orcid.org/0000-0002-8394-9056"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amin Nomeir","raw_affiliation_strings":["Merck Research Laboratories, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Kenilworth, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063440637","display_name":"Marla L. Weetall","orcid":"https://orcid.org/0000-0002-2013-8096","observed_orcids":["https://orcid.org/0000-0002-2013-8096"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marla Weetall","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087990265","display_name":"Neil G. Almstead","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil G. Almstead","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076684353","display_name":"Stuart W. Peltz","orcid":"https://orcid.org/0000-0002-9158-9142","observed_orcids":["https://orcid.org/0000-0002-9158-9142"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart W. Peltz","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xiao Tong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiao Tong","raw_affiliation_strings":["Merck Research Laboratories, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Kenilworth, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033490987","display_name":"Robert Ralston","orcid":"https://orcid.org/0009-0003-3202-2116","observed_orcids":["https://orcid.org/0009-0003-3202-2116"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Ralston","raw_affiliation_strings":["Merck Research Laboratories, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Kenilworth, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087545685","display_name":"Joseph M. Colacino","orcid":"https://orcid.org/0000-0002-0939-2341","observed_orcids":["https://orcid.org/0000-0002-0939-2341"]},"institutions":[{"id":"https://openalex.org/I4210134724","display_name":"PTC Therapeutics (United States)","ror":"https://ror.org/03jz67a83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134724"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Colacino","raw_affiliation_strings":["PTC Therapeutics, Inc., South Plainfield, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTC Therapeutics, Inc., South Plainfield, New Jersey, USA","institution_ids":["https://openalex.org/I4210134724"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.4771,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.88466351,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":98},"biblio":{"volume":"57","issue":"7","first_page":"3250","last_page":"3261"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.9629999995231628},{"id":"https://openalex.org/keywords/ns4b-protein","display_name":"NS4B protein","score":0.871999979019165},{"id":"https://openalex.org/keywords/direct-acting-antivirals","display_name":"direct-acting antivirals","score":0.8360000252723694},{"id":"https://openalex.org/keywords/hcv-replicon","display_name":"HCV replicon","score":0.7450000047683716},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7329999804496765},{"id":"https://openalex.org/keywords/ns3-protease-inhibitors","display_name":"NS3 protease inhibitors","score":0.6800000071525574},{"id":"https://openalex.org/keywords/ns5b-polymerase-inhibitors","display_name":"NS5B polymerase inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6119999885559082},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8050000071525574},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9890000224113464},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C2777103181","wikidata":"https://www.wikidata.org/wiki/Q83141840","display_name":"NS5A","level":5,"score":0.8100153207778931},{"id":"https://openalex.org/C18103114","wikidata":"https://www.wikidata.org/wiki/Q1720369","display_name":"Replicon","level":4,"score":0.7572488784790039},{"id":"https://openalex.org/C132379496","wikidata":"https://www.wikidata.org/wiki/Q83141645","display_name":"NS3","level":4,"score":0.7349236011505127},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.6632977724075317},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5797477960586548},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5281816720962524},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4891257882118225},{"id":"https://openalex.org/C2781463415","wikidata":"https://www.wikidata.org/wiki/Q2082778","display_name":"Hepacivirus","level":4,"score":0.4827982187271118},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.4595358371734619},{"id":"https://openalex.org/C2781426373","wikidata":"https://www.wikidata.org/wiki/Q24766653","display_name":"NS5B","level":5,"score":0.4499109089374542},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.446820467710495},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.42073509097099304},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.18037158250808716},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.150314599275589},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1082351803779602},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09384080767631531},{"id":"https://openalex.org/C22744801","wikidata":"https://www.wikidata.org/wiki/Q172778","display_name":"Plasmid","level":3,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017361","descriptor_name":"Viral Nonstructural Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017361","descriptor_name":"Viral Nonstructural Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019943","descriptor_name":"Amino Acid Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.00527-13","doi":"https://doi.org/10.1128/aac.00527-13","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00527-13","pdf_url":"https://aac.asm.org/content/aac/57/7/3250.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2698785","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3697315","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:23629699","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23629699","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3697315","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3697315/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1128/aac.00527-13","doi":"https://doi.org/10.1128/aac.00527-13","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00527-13","pdf_url":"https://aac.asm.org/content/aac/57/7/3250.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139052378.pdf"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W65531902","https://openalex.org/W1497131577","https://openalex.org/W1604589676","https://openalex.org/W1963595375","https://openalex.org/W1964963193","https://openalex.org/W1969002466","https://openalex.org/W1971462411","https://openalex.org/W1978866862","https://openalex.org/W1983186031","https://openalex.org/W1984897642","https://openalex.org/W1989831705","https://openalex.org/W1994454535","https://openalex.org/W2003009082","https://openalex.org/W2009054488","https://openalex.org/W2012282947","https://openalex.org/W2015216410","https://openalex.org/W2027179985","https://openalex.org/W2031220581","https://openalex.org/W2031742259","https://openalex.org/W2042476079","https://openalex.org/W2045408147","https://openalex.org/W2047804901","https://openalex.org/W2053223278","https://openalex.org/W2054486572","https://openalex.org/W2054832065","https://openalex.org/W2075047152","https://openalex.org/W2077675989","https://openalex.org/W2077945404","https://openalex.org/W2078770660","https://openalex.org/W2078887917","https://openalex.org/W2079289661","https://openalex.org/W2083331673","https://openalex.org/W2098432187","https://openalex.org/W2103991814","https://openalex.org/W2104356883","https://openalex.org/W2106062927","https://openalex.org/W2106927931","https://openalex.org/W2110671968","https://openalex.org/W2113749416","https://openalex.org/W2113923090","https://openalex.org/W2119303435","https://openalex.org/W2123893936","https://openalex.org/W2128237394","https://openalex.org/W2132444008","https://openalex.org/W2132492420","https://openalex.org/W2142277942","https://openalex.org/W2145623055","https://openalex.org/W2145631850","https://openalex.org/W2147206362","https://openalex.org/W2147229822","https://openalex.org/W2150639096","https://openalex.org/W2151898297","https://openalex.org/W2157843875","https://openalex.org/W2168307424","https://openalex.org/W2170010634","https://openalex.org/W2277928119"],"related_works":["https://openalex.org/W2520005221","https://openalex.org/W2159294886","https://openalex.org/W1999239109","https://openalex.org/W2075047152","https://openalex.org/W2135516441","https://openalex.org/W2003009082","https://openalex.org/W2401553014","https://openalex.org/W2130921346","https://openalex.org/W2113923090"],"abstract_inverted_index":{"While":[0],"new":[1,30],"direct-acting":[2],"antiviral":[3,25],"agents":[4,26],"for":[5,23,128,230],"the":[6,47,70,167,171,175,222,226,233],"treatment":[7,234],"of":[8,49,62,87,93,120,143,157,178,187,205,228,235],"chronic":[9,236],"hepatitis":[10],"C":[11],"virus":[12],"(HCV)":[13],"infection":[14],"have":[15,57],"been":[16],"approved,":[17],"there":[18],"is":[19,219],"a":[20,59,82,98,190,212],"continued":[21],"need":[22],"novel":[24,60],"that":[27,68,115,165,211],"act":[28],"on":[29],"targets":[31],"and":[32,44,90,96,123,137,160,197,202],"can":[33],"be":[34],"used":[35],"in":[36,139,149,182,200,208,232],"combination":[37,150],"with":[38,81,102,151,155,194],"current":[39],"therapies":[40],"to":[41,45,104,118,130,147],"enhance":[42],"efficacy":[43],"restrict":[46],"emergence":[48],"drug-resistant":[50],"viral":[51],"variants.":[52],"To":[53],"this":[54],"end,":[55],"we":[56],"identified":[58],"class":[61],"small":[63],"molecules,":[64],"exemplified":[65],"by":[66],"PTC725,":[67],"target":[69],"nonstructural":[71],"protein":[72],"4B":[73],"(NS4B).":[74],"PTC725":[75,131,144,188,229],"inhibited":[76],"HCV":[77,112,158,168,237],"1b":[78],"(Con1)":[79],"replicons":[80],"50%":[83],"effective":[84],"concentration":[85],"(EC50)":[86],"1.7":[88],"nM":[89,95],"an":[91],"EC90":[92],"9.6":[94],"demonstrated":[97,164],">1,000-fold":[99],"selectivity":[100],"window":[101],"respect":[103],"cytotoxicity.":[105],"The":[106],"compounds":[107],"were":[108],"fully":[109],"active":[110],"against":[111],"replicon":[113,183],"mutants":[114],"are":[116],"resistant":[117],"inhibitors":[119,156,169],"NS3":[121],"protease":[122,159],"NS5B":[124],"polymerase.":[125,161],"Replicons":[126],"selected":[127],"resistance":[129],"harbored":[132],"amino":[133],"acid":[134],"substitutions":[135],"F98L/C":[136],"V105M":[138],"NS4B.":[140],"Anti-replicon":[141],"activity":[142],"was":[145],"additive":[146],"synergistic":[148],"alpha":[152],"interferon":[153],"or":[154,180,214],"Immunofluorescence":[162],"microscopy":[163],"neither":[166],"nor":[170],"F98C":[172],"substitution":[173],"altered":[174],"subcellular":[176],"localization":[177],"NS4B":[179],"NS5A":[181],"cells.":[184],"Oral":[185],"dosing":[186,206,217],"showed":[189],"favorable":[191],"pharmacokinetic":[192],"profile":[193],"high":[195],"liver":[196],"plasma":[198],"exposure":[199],"mice":[201],"rats.":[203],"Modeling":[204],"regimens":[207],"humans":[209],"indicates":[210],"once-per-day":[213],"twice-per-day":[215],"oral":[216],"regimen":[218],"feasible.":[220],"Overall,":[221],"preclinical":[223],"data":[224],"support":[225],"development":[227],"use":[231],"infection.":[238]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}